eyenovia-logo 3

FAQS

When did Eyenovia go public?
Eyenovia’s common stock began trading on January 25, 2018. The IPO consisted of 2,730,000 shares at $10 per share.
Where is Eyenovia’s stock traded?
Eyenovia’s shares are traded on the Nasdaq Capital markets under the symbol “EYEN”.
What is Eyenovia’s CUSIP number?
Eyenovia’s CUSIP number is 30234E 104.
Where are Eyenovia’s headquarters located?
New York 501 Fifth Avenue, Suite 1404 New York NY 10017
When do Eyenovia’s fiscal quarters end?
First Quarter: March 31
Second Quarter: June 30
Third Quarter: September 30
Fourth Quarter: December 31
Who are Eyenovia’s independent auditors?
Marcum LLP
What are Eyenovia’s corporate governance guidelines?
To review our corporate governance guidelines and related information, please go to the Corporate Governance section of our IR website.
How can I buy Eyenovia’s stock?
You may purchase Eyenovia’s stock through a registered stockbroker.
Who should I contact with questions about my stock ownership?
Beneficial stockholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered stockholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Eyenovia’s transfer agent.
Who is Eyenovia’s transfer agent and what is their contact information?
The transfer agent and registrar for Eyenovia’s common stock is Amer. Stock Transfer. The transfer agent and registrar’s address is 6201 15th Ave. Brooklyn, NY 11219.
Where can I find financial information about Eyenovia?
Eyenovia will file periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on the SEC Filings page. In addition, Eyenovia will post recent financial information in the form of quarterly earnings press releases, webcasts and presentations on its Investor Relations website.
Who should I contact if I have more questions about investing in Eyenovia?
You can reach Eyenovia’ Investor Relations team via e-mail at, [email protected] or [email protected].

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

New York    501 Fifth Avenue, Suite 1404 New York NY 10017     +1 (917) 289-1117

[email protected]